BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 15466656)

  • 21. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
    Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
    Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
    Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9.
    Iwakura A; Shastry S; Luedemann C; Hamada H; Kawamoto A; Kishore R; Zhu Y; Qin G; Silver M; Thorne T; Eaton L; Masuda H; Asahara T; Losordo DW
    Circulation; 2006 Mar; 113(12):1605-14. PubMed ID: 16534014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
    Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
    J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism.
    Li J; Zhang Y; Li C; Xie J; Liu Y; Zhu W; Zhang X; Jiang S; Liu L; Ding Z
    Cardiovasc Res; 2013 Sep; 99(4):674-84. PubMed ID: 23729663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
    Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
    Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
    Zhou MS; Jaimes EA; Raij L
    Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.
    Martin JH; Connelly KA; Boyle A; Kompa A; Zhang Y; Kelly D; Gilbert RE; Krum H
    Int J Cardiol; 2010 Sep; 143(3):353-60. PubMed ID: 19395095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
    Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
    Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
    Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats.
    Chang CZ; Wu SC; Lin CL; Hwang SL; Howng SL; Kwan AL
    Acta Neurochir (Wien); 2010 Aug; 152(8):1399-406; discussion 1405-6. PubMed ID: 20440630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
    Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
    Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F
    Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.
    Toko H; Zou Y; Minamino T; Masaya M; Harada M; Nagai T; Sugaya T; Terasaki F; Kitaura Y; Komuro I
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):664-70. PubMed ID: 14962948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarction.
    Spooner PH; Thai HM; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2004 Oct; 44(4):453-9. PubMed ID: 15454853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise Training Has Contrasting Effects in Myocardial Infarction and Pressure Overload Due to Divergent Endothelial Nitric Oxide Synthase Regulation.
    van Deel ED; Octavia Y; de Waard MC; de Boer M; Duncker DJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
    Yang XP; Liu YH; Shesely EG; Bulagannawar M; Liu F; Carretero OA
    Hypertension; 1999 Jul; 34(1):24-30. PubMed ID: 10406819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.